Replimune (REPL) Invested Capital (2018 - 2025)
Replimune has reported Invested Capital over the past 8 years, most recently at $235.5 million for Q4 2025.
- Quarterly results put Invested Capital at $235.5 million for Q4 2025, down 53.64% from a year ago — trailing twelve months through Dec 2025 was $235.5 million (down 53.64% YoY), and the annual figure for FY2025 was $462.2 million, up 10.23%.
- Invested Capital reached $235.5 million in Q4 2025 per REPL's latest filing, down from $288.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $622.0 million in Q4 2022 and bottomed at $235.5 million in Q4 2025.
- Median Invested Capital over the past 5 years was $457.3 million (2024), compared with a mean of $451.7 million.
- The largest annual shift saw Invested Capital skyrocketed 157.72% in 2021 before it crashed 53.64% in 2025.
- Over 5 years, Invested Capital stood at $464.6 million in 2021, then surged by 33.9% to $622.0 million in 2022, then fell by 28.01% to $447.8 million in 2023, then increased by 13.46% to $508.1 million in 2024, then plummeted by 53.64% to $235.5 million in 2025.
- Business Quant data shows Invested Capital for REPL at $235.5 million in Q4 2025, $288.5 million in Q3 2025, and $362.1 million in Q2 2025.